Calithera_Logo_Primary_RGB_M01.jpg
Final Data from Calithera Biosciences’ Phase 2 CANTATA Study in Renal Cell Carcinoma Presented at 2021 ASCO Annual Meeting
June 07, 2021 08:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera to Present at the Jefferies 2021 Virtual Healthcare Conference
May 27, 2021 07:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708
May 17, 2021 08:00 ET | Calithera Biosciences, Inc.
--CB-708 is an oral small molecule inhibitor of CD73 in preclinical development for oncology--Antengene is granted exclusive rights to develop and commercialize asset discovered and initially...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights
May 06, 2021 16:05 ET | Calithera Biosciences, Inc.
--$102.9 Million in Cash and Investments at March 31, 2021-- -- Conference Call and Webcast Scheduled for 2:00 p.m. PT on May 6, 2021-- SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
April 30, 2021 07:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Results from Calithera Biosciences’ CANTATA Study to Be Presented at 2021 ASCO Annual Meeting
April 28, 2021 07:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights
March 16, 2021 16:06 ET | Calithera Biosciences, Inc.
--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on March 16, 2021-- SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Calithera...
Calithera_Logo_Primary_RGB_M01.jpg
UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021
March 12, 2021 15:09 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021
March 10, 2021 07:05 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
Calithera_Logo_Primary_RGB_M01.jpg
Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference
March 02, 2021 07:00 ET | Calithera Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...